📊 ATAI Key Takeaways
Is Atai Beckley N.V. (ATAI) a Good Investment?
Atai Beckley N.V. exhibits severe financial distress with a pre-revenue or near-zero revenue business model generating massive operating losses of -74.1M on just 3.0M in revenue. The company is burning cash rapidly with -55.2M in operating cash flow and -56.0M in free cash flow, depleting its limited cash reserves despite maintaining a strong balance sheet from recent capital raises.
Atai Beckley N.V.'s fundamentals remain weak: revenue is minimal and declining, while operating and net losses are exceptionally large relative to sales. The balance sheet is currently supported by high liquidity and no long-term debt, but negative free cash flow and a cash balance below one year of recent operating burn raise meaningful funding-risk concerns unless the company materially improves commercialization or secures new capital.
Why Buy Atai Beckley N.V. Stock? ATAI Key Strengths
- Strong liquidity position with 7.90x current ratio and 30.4M cash on hand
- Zero long-term debt providing financial flexibility
- Equity cushion of 159.8M limiting immediate solvency risk
- Debt-free balance sheet with no long-term debt reducing financial leverage risk
- Strong near-term liquidity ratios indicate current obligations are well covered
- Positive equity base and sizable total assets provide some balance-sheet flexibility
ATAI Stock Risks: Atai Beckley N.V. Investment Risks
- Massive operating losses of -74.1M with negative operating margin of -2450.5% indicating unsustainable business model
- Severe cash burn rate of -56.0M annually will deplete cash reserves in approximately 6 months at current rate
- Revenue of 3.0M is minimal and declining YoY, suggesting product commercialization failure or pre-revenue status
- Net losses of -115.2M with negative ROE of -72.1% and ROA of -48.1% indicate fundamental value destruction
- No clear path to profitability with operating expenses far exceeding revenue generation capacity
- Extreme negative operating and net margins show the business is far from self-sustaining
- Operating cash burn is heavy relative to cash on hand, implying limited runway without improvement or external funding
- Revenue base is very small and declined year over year, indicating weak growth quality and limited operating traction
Key Metrics to Watch
- Quarterly revenue growth trajectory and new product launches
- Operating cash burn rate and remaining cash runway
- Operating expense reduction progress and path to profitability
- Progress on clinical trials or regulatory approvals if pharmaceutical development company
- Working capital management and cash depletion timeline
- Cash and equivalents relative to quarterly operating cash burn
- Revenue growth and operating loss trend
Atai Beckley N.V. (ATAI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 7.90x current ratio provides a solid financial cushion.
ATAI Profit Margin, ROE & Profitability Analysis
ATAI vs Healthcare Sector: How Atai Beckley N.V. Compares
How Atai Beckley N.V. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Atai Beckley N.V. Stock Overvalued? ATAI Valuation Analysis 2026
Based on fundamental analysis, Atai Beckley N.V. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Atai Beckley N.V. Balance Sheet: ATAI Debt, Cash & Liquidity
ATAI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Atai Beckley N.V.'s revenue has declined by 98% over the 5-year period, indicating business contraction. The most recent EPS of $-0.25 indicates the company is currently unprofitable.
ATAI Revenue Growth, EPS Growth & YoY Performance
ATAI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $40.0K | -$26.3M | $-0.16 |
| Q2 2025 | $273.0K | -$27.7M | $-0.14 |
| Q1 2025 | N/A | -$26.4M | $-0.15 |
| Q3 2024 | $40.0K | -$21.9M | $-0.14 |
| Q2 2024 | $172.0K | -$33.0M | $-0.21 |
| Q1 2024 | N/A | -$26.7M | $-0.17 |
| Q3 2023 | $24.0K | -$21.9M | $-0.14 |
| Q2 2023 | $170.0K | -$33.0M | $-0.21 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Atai Beckley N.V. Dividends, Buybacks & Capital Allocation
ATAI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Atai Beckley N.V. (CIK: 0001840904)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ATAI
What is the AI rating for ATAI?
Atai Beckley N.V. (ATAI) has a Combined AI Rating of SELL from Claude (STRONG SELL) and ChatGPT (SELL) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ATAI's key strengths?
Claude: Strong liquidity position with 7.90x current ratio and 30.4M cash on hand. Zero long-term debt providing financial flexibility. ChatGPT: Debt-free balance sheet with no long-term debt reducing financial leverage risk. Strong near-term liquidity ratios indicate current obligations are well covered.
What are the risks of investing in ATAI?
Claude: Massive operating losses of -74.1M with negative operating margin of -2450.5% indicating unsustainable business model. Severe cash burn rate of -56.0M annually will deplete cash reserves in approximately 6 months at current rate. ChatGPT: Extreme negative operating and net margins show the business is far from self-sustaining. Operating cash burn is heavy relative to cash on hand, implying limited runway without improvement or external funding.
What is ATAI's revenue and growth?
Atai Beckley N.V. reported revenue of $3.0M.
Does ATAI pay dividends?
Atai Beckley N.V. does not currently pay dividends.
Where can I find ATAI SEC filings?
Official SEC filings for Atai Beckley N.V. (CIK: 0001840904) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ATAI's EPS?
Atai Beckley N.V. has a diluted EPS of $-0.59.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ATAI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Atai Beckley N.V. has a SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ATAI stock overvalued or undervalued?
Valuation metrics for ATAI: ROE of -72.1% (sector avg: 15%), net margin of -3,811.9% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ATAI stock in 2026?
Our dual AI analysis gives Atai Beckley N.V. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ATAI's free cash flow?
Atai Beckley N.V.'s operating cash flow is $-55.2M, with capital expenditures of $791.0K. FCF margin is -1,852.0%.
How does ATAI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -3,811.9% (avg: 12%), ROE -72.1% (avg: 15%), current ratio 7.90 (avg: 2).